MUMBAI, Feb 27 (Reuters) - India's drug regulator aims to implement various reforms, including streamlining export clearances for unapproved drugs and simplifying the manufacturing licensing process, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results